<DOC>
	<DOCNO>NCT00855634</DOCNO>
	<brief_summary>PaMeViTUM mono-centric prospective randomize control trial compare different operating procedure patient pancreatic cancer minimal metastatic disease venous infiltration .</brief_summary>
	<brief_title>Resection Pancreatic Cancer With Minimal Metastatic Disease Venous Infiltration Trial Technische Universität München</brief_title>
	<detailed_description>PaMeViTUM mono-centric prospective randomize control trial compare different operating procedure patient pancreatic cancer minimal metastatic disease venous infiltration . Patients randomize intraoperatively fulfil inclusion criterion ( particular : suspicion cancer pancreas intraoperative histologically proven diagnosis pancreatic adenocarcinoma ; intraoperative assessment tumor potentially locally respectable ) . If metastasis infiltration portal vein detect operation , standard resection perform ( tumor pancreatic head : ( pylorus-preserving ) pancreaticoduodenectomy ; tumor pancreatic body/tail : distal ( leave ) pancreatic resection ; tumor head body/tail : total pancreatectomy ) . In case tumor infiltration pyloric region distal stomach , classical pancreaticoduodenectomy perform . If patient pancreatic cancer minimal metastatic disease ( COHORT 1 ) fulfills inclusion criterion , she/he randomize one follow arm : - Arm 1 ( intervention ) : resection primary tumor , follow resection liver metastasis/metastases - Arm 2 ( control ) : exploration and/or gastroenterostomy and/or hepaticojejunostomy/choledochojejunostomy If liver metastasis , follow mobilization ( potentially also dissection pancreas pancreatic head ) , extension tumor towards superior mesenteric/splenic/portal vein examine . If venous infiltration ( COHORT 2 ) patient fulfills inclusion criterion , she/he randomize one follow arm : - Arm 1 ( intervention ) : resection primary tumor resection portal vein ( and/or superior mesenteric vein/splenic vein ( SMV/SV ) - Arm 2 ( control ) : resection primary tumor dissection portal vein ( and/or superior mesenteric vein/splenic vein ( SMV/SV ) plus tumor mass adjacent vein ; venous resection The aim study demonstrate extension resectability criterion patient pancreatic cancer 1 ) minimal metastatic disease OR 2 ) venous infiltration improve overall survival . A secondary aim study prove resection patient cohorts improve quality life .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>suspicion cancer pancreas intraoperative histologically proven diagnosis pancreatic adenocarcinoma . intraoperative assessment tumor potentially locally resectable COHORT 1 : Minimal metastatic disease COHORT 2 : Venous infiltration ability sign inform consent . Karnofsky performance status &gt; 70 . Lifeexpectancy 3 month . able attend followup . previous concurrent malignancy diagnosis , except nonmelanoma skin cancer situ carcinoma cervix . serious medical , psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup . patient older 18 year . pregnant lactating woman . preoperative evaluation thinsliced CT scan : No evidence substantial extrapancreatic disease , i.e . evidence malignant ascites , extend liver metastasis ( &gt; 5 metastatic lesion ) , spread distant abdominal organ , peritoneal metastasis , spread extraabdominal organ . No evidence extension tumor celiac axis superior mesenteric artery ( T4 disease ) . intraoperative finding : tumor assess potentially locally resectable . sign peritoneal metastasis tumor manifestation outside pancreas liver . frozen section : adenocarcinoma extrapancreatic disease ( except minimal metastatic disease liver , see ) concomitant venous infiltration minimal metastatic disease extension tumor celiac axis superior mesenteric artery life expectancy le 3 month previous concurrent malignancy diagnosis , except nonmelanoma skin cancer situ carcinoma cervix condition potentially hamper compliance ( also inclusion criterion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Pancreatic cancer</keyword>
	<keyword>metastasis</keyword>
	<keyword>venous infiltration</keyword>
	<keyword>Pancreatic cancer minimal metastatic disease venous infiltration</keyword>
</DOC>